Evidence map›Paper›PMID 39948241›Full record

ArticleVirchows Archiv : an international journal of pathology2025

AI-based tumor-stroma ratio quantification algorithm: comprehensive evaluation of prognostic role in primary colorectal cancer.

Rita Carvalho, Thomas Zander, Vincenzo Mitchell Barroso, Ahmet Bekisoglu, Norman Zerbe, Sebastian Klein, Reinhard Büttner, Alexander Quaas, Yuri Tolkach

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rita CarvalhoInstitute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Thomas ZanderClinic of Internal Medicine, Oncology, University Hospital Cologne, Cologne, Germany.
Vincenzo Mitchell BarrosoMedical Faculty, University of Cologne, Cologne, Germany.
Ahmet BekisogluMedical Faculty, University of Cologne, Cologne, Germany.
Norman ZerbeInstitute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Sebastian KleinInsitute of Pathology, University Hospital Cologne, Cologne, Germany.
Reinhard BüttnerInsitute of Pathology, University Hospital Cologne, Cologne, Germany.
Alexander QuaasInsitute of Pathology, University Hospital Cologne, Cologne, Germany.
Yuri TolkachInsitute of Pathology, University Hospital Cologne, Cologne, Germany. yuri.tolkach@gmail.com.ORCID http://orcid.org/0000-0001-5239-2841

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor-stroma ratio (TSR quantification in primary colorectal cancer is an important prognostic parameter, with stroma-rich tumors considered to have an unfavorable prognosis. Earlier studies involved relevant region selection and TSR quantification by human analysts, who are prone to interobserver variability. The aim of the current study was to develop a fully automated, quantitative algorithm for TSR analysis based on precise segmentation of H&E-stained histological tissue sections. The TSR quantification algorithm was developed based on the segmentation backbone, allowing accurate pixel-wise mapping of all relevant tissue classes (n = 12), including tumor cells, tumoral stroma, necrosis, and mucin. Three well-characterized cohorts of patients with stage I-IV primary operable colorectal cancer and available digital H&E histological slides were included (n = 548, n = 147, and n = 622, respectively). Three sizes of area for TSR analysis were tested (1.0, 1.5, and 2.0 mm). The maximal TSR value per case was used for prognostic analysis involving different clinical endpoints. Regional heterogeneity of TSR was high in most tumors, with the algorithm effectively finding the most relevant region for analysis. Maximal case-level TSR values depended on the size of the area for analysis, which also significantly influences the prognostic performance of the TSR and must be a matter of standardization. In Cox analysis, an analytical size of 1 mm allowed the best performance, with an independent prognostic role retained in the context of other pathological variables for progression-free survival, cancer-specific survival, and overall survival endpoints. A powerful, fully automated, fully quantitative, objective tool for TSR assessment in primary colorectal cancer was developed and validated to have independent prognostic value. Standardization of TSR quantification is important given that analytical parameters can substantially influence the prognostic performance.

Indexed as

AlgorithmsArtificial IntelligenceColorectal NeoplasmsImage Interpretation, Computer-AssistedStromal CellsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedNeoplasm StagingPredictive Value of TestsPrognosisAI algorithmColorectal cancerDigital pathologyPrognosisTumor-stroma ratio

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.